New Zealand markets open in 2 hours 6 minutes

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
987.87+6.67 (+0.68%)
As of 01:53PM EST. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts18182423
Avg. Estimate10.0211.0644.8547.26
Low estimate8.419.6536.4841.27
High estimate12.3412.7552.656.4
Year ago EPS10.0910.2443.7944.85
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts16152322
Avg. Estimate3.24B3.4B13.92B14.95B
Low estimate3B3.23B13.04B13.9B
High estimate3.51B3.65B14.75B17.18B
Year ago sales3BN/A13.12B13.92B
Sales growth (year/est)8.10%N/A6.10%7.40%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS9.569.8410.7210.73
Actual EPS10.0910.2411.5911.86
Difference0.530.40.871.13
Surprise %5.50%4.10%8.10%10.50%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate10.0211.0644.8547.26
7 days ago10.0211.0644.9147.31
30 days ago10.411.2244.7348.01
60 days ago10.3211.5644.2948.29
90 days ago10.2411.3343.346.78
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days37147
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesREGNIndustrySector(s)S&P 500
Current qtr.-0.70%N/AN/AN/A
Next qtr.8.00%N/AN/AN/A
Current year2.40%N/AN/AN/A
Next year5.40%N/AN/AN/A
Next 5 years (per annum)7.36%N/AN/AN/A
Past 5 years (per annum)17.45%N/AN/AN/A